{
    "2019-11-01": [
        [
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：叶小平累计减持764.03万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "叶小平",
                        "减持",
                        "764.03万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：控股股东、实际控制人减持股份数量达1% 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "控股股东",
                        "实际控制人",
                        "减持",
                        "1%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "创新药由“中国新”变为“全球新”，4家CRO被看好",
                "features": {
                    "keywords": [
                        "创新药",
                        "全球新",
                        "CRO",
                        "被看好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}